C1-INHIBITOR CONCENTRATE For acute attacks of hereditary angioedema

InPharma ◽  
1980 ◽  
Vol 252 (1) ◽  
pp. 13-13
Keyword(s):  
Hereditary Angioedema ◽  
C1 Inhibitor ◽  
Acute Attacks

Clinical Studies of Recombinant Human C1 Inhibitor (rhC1INH) in Patients with Acute Attacks of Hereditary Angioedema

2008 ◽  
Vol 121 (3) ◽  
pp. 797 ◽  
Author(s):  
J. Nuijens ◽  
R. Verdonk ◽  
B. Giannetti ◽  
S. Visscher ◽  
M. van Doorn ◽  
...  
Keyword(s):  
Hereditary Angioedema ◽  
Clinical Studies ◽  
C1 Inhibitor ◽  
Acute Attacks

scholarly journals Switch to Icatibant in a Patient Affected by Hereditary Angioedema with High Disease Activity: A Case Report

2012 ◽  
Vol 25 (1) ◽  
pp. 269-273
Author(s):  
D. Firinu ◽  
M.P. Barca ◽  
L. Serusi ◽  
M.M. Lorrai ◽  
M.M. Peralta ◽  
...  
Keyword(s):  
Case Report ◽  
Disease Activity ◽  
Hereditary Angioedema ◽  
High Disease Activity ◽  
C1 Inhibitor ◽  
Bradykinin B2 Receptor ◽  
Acute Attacks ◽  
The Eu

Icatibant, an antagonist of the bradykinin B2 receptor, was approved for the treatment of acute attacks of hereditary angioedema in the EU in 2008. This paper presents the case of a 65-year-old woman affected by frequent acute attacks of hereditary angioedema who benefitted from a change of therapy to icatibant, following years of treatment with C1-inhibitor.

scholarly journals Opinions of Turkish Hereditary Angioedema Patients Regarding the Use of C1 Inhibitor Concentrate in the Treatment of Acute Attacks

2019 ◽  
Author(s):  
Semra Demir ◽  
Müge Olgaç ◽  
Derya Ünal ◽  
Raif Coşkun ◽  
Aslı Gelincik ◽  
...  
Keyword(s):  
Hereditary Angioedema ◽  
C1 Inhibitor ◽  
Acute Attacks
Sign in / Sign up

Export Citation Format

Share Document